Literature DB >> 25655803

Mitochondrial morphology differences and mitophagy deficit in murine glaucomatous optic nerve.

Lucy Coughlin1, Richard S Morrison2, Philip J Horner2, Denise M Inman3.   

Abstract

PURPOSE: Decreased ATP correlates with intraocular pressure exposure in the optic nerves of mice with glaucoma. To understand what underlies this energy deficit, we examined mitochondria in the myelinated optic nerve axons of the DBA/2J mouse, a model of glaucoma secondary to iris pigment disease, and the DBA/2(wt-gpnmb) control strain.
METHODS: Mitochondrial length, width, surface area, and health status were measured in 30 electron microscopic fields within the myelinated portion of optic nerves from DBA/2J and DBA/2(wt-gpnmb) mice at 3, 6, and 10 months of age. Protein was isolated from optic nerve for analysis of PINK1, Parkin, LC3-I and -II, and lysosome-associated membrane protein 1 (LAMP1) by Western blot.
RESULTS: The number of mitochondria in DBA/2J optic nerve was increased, and they had significantly smaller surface area. Mitochondria in DBA/2J were closer to the axolemma, more spatially isolated, and their cristae were more disrupted at every age group as compared to DBA/2(wt-gpnmb). Autophagosomes were significantly increased in DBA/2J optic nerve at all ages. Protein analysis showed higher LC3-II to LC3-I ratio in aged DBA/2J optic nerve than in DBA/2(wt-gpnmb). PINK1 and Parkin levels were not statistically different across age groups. LAMP1 was significantly decreased in the aged DBA/2J optic nerve.
CONCLUSIONS: Decreased surface area, combined with reduced oxidative capacity in mitochondria from the aged DBA/2J axon, indicate that mitochondrial pathology may contribute to the energy deficit in glaucomatous optic nerve. Though autophagosomes were increased in DBA/2J optic nerve, the increased mitochondria and decreased LAMP1 suggest deteriorating mitochondria are not being efficiently recycled by mitophagy. Copyright 2015 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  autophagosome; mitochondria; mitophagy

Mesh:

Substances:

Year:  2015        PMID: 25655803      PMCID: PMC4347310          DOI: 10.1167/iovs.14-16126

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  32 in total

1.  Activity-dependent regulation of mitochondrial motility by calcium and Na/K-ATPase at nodes of Ranvier of myelinated nerves.

Authors:  Chuan Li Zhang; Po Lai Ho; Douglas B Kintner; Dandan Sun; Shing Yan Chiu
Journal:  J Neurosci       Date:  2010-03-10       Impact factor: 6.167

Review 2.  A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine.

Authors:  Douglas C Wallace
Journal:  Annu Rev Genet       Date:  2005       Impact factor: 16.830

3.  Progressive loss of retinal ganglion cell function precedes structural loss by several years in glaucoma suspects.

Authors:  Michael R Banitt; Lori M Ventura; William J Feuer; Eleonore Savatovsky; Gabriel Luna; Olga Shif; Brandon Bosse; Vittorio Porciatti
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-28       Impact factor: 4.799

4.  Distal axonopathy with structural persistence in glaucomatous neurodegeneration.

Authors:  Samuel D Crish; Rebecca M Sappington; Denise M Inman; Philip J Horner; David J Calkins
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

5.  Metabolic vulnerability disposes retinal ganglion cell axons to dysfunction in a model of glaucomatous degeneration.

Authors:  Selva Baltan; Denise M Inman; Camelia A Danilov; Richard S Morrison; David J Calkins; Philip J Horner
Journal:  J Neurosci       Date:  2010-04-21       Impact factor: 6.167

6.  The micro-architecture of mitochondria at active zones: electron tomography reveals novel anchoring scaffolds and cristae structured for high-rate metabolism.

Authors:  Guy A Perkins; Jonathan Tjong; Joshua M Brown; Patrick H Poquiz; Raymond T Scott; Douglas R Kolson; Mark H Ellisman; George A Spirou
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

7.  Longitudinal evaluation of retinal ganglion cell function and IOP in the DBA/2J mouse model of glaucoma.

Authors:  Maher Saleh; Mahesh Nagaraju; Vittorio Porciatti
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

8.  Elevated hydrostatic pressure triggers mitochondrial fission and decreases cellular ATP in differentiated RGC-5 cells.

Authors:  Won-Kyu Ju; Quan Liu; Keun-Young Kim; Jonathan G Crowston; James D Lindsey; Neeraj Agarwal; Mark H Ellisman; Guy A Perkins; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-05       Impact factor: 4.799

9.  Anterograde transport blockade precedes deficits in retrograde transport in the visual projection of the DBA/2J mouse model of glaucoma.

Authors:  Christine M Dengler-Crish; Matthew A Smith; Denise M Inman; Gina N Wilson; Jesse W Young; Samuel D Crish
Journal:  Front Neurosci       Date:  2014-09-17       Impact factor: 4.677

Review 10.  Self and nonself: how autophagy targets mitochondria and bacteria.

Authors:  Felix Randow; Richard J Youle
Journal:  Cell Host Microbe       Date:  2014-04-09       Impact factor: 21.023

View more
  42 in total

Review 1.  BAX to basics: How the BCL2 gene family controls the death of retinal ganglion cells.

Authors:  Margaret E Maes; Cassandra L Schlamp; Robert W Nickells
Journal:  Prog Retin Eye Res       Date:  2017-01-04       Impact factor: 21.198

2.  Decreased Energy Capacity and Increased Autophagic Activity in Optic Nerve Axons With Defective Anterograde Transport.

Authors:  David Kleesattel; Samuel D Crish; Denise M Inman
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

3.  Mitochondrial Uncoupling Protein 2 Knock-out Promotes Mitophagy to Decrease Retinal Ganglion Cell Death in a Mouse Model of Glaucoma.

Authors:  Daniel T Hass; Colin J Barnstable
Journal:  J Neurosci       Date:  2019-02-27       Impact factor: 6.167

4.  Age-related accumulation of phosphorylated mitofusin 2 protein in retinal ganglion cells correlates with glaucoma progression.

Authors:  Mary P Nivison; Nolan G Ericson; Virginia M Green; Jason H Bielas; Jean S Campbell; Philip J Horner
Journal:  Exp Neurol       Date:  2017-07-03       Impact factor: 5.330

5.  A mouse ocular explant model that enables the study of living optic nerve head events after acute and chronic intraocular pressure elevation: Focusing on retinal ganglion cell axons and mitochondria.

Authors:  Elizabeth C Kimball; Mary E Pease; Matthew R Steinhart; Ericka N Oglesby; Ian Pitha; Cathy Nguyen; Harry A Quigley
Journal:  Exp Eye Res       Date:  2017-04-14       Impact factor: 3.467

Review 6.  Pathophysiology of Conversion to Symptomatic Leber Hereditary Optic Neuropathy and Therapeutic Implications: a Review.

Authors:  Alvaro J Mejia-Vergara; Nicolas Seleme; Alfredo A Sadun; Rustum Karanjia
Journal:  Curr Neurol Neurosci Rep       Date:  2020-04-15       Impact factor: 5.081

7.  Structural and Functional Rescue of Chronic Metabolically Stressed Optic Nerves through Respiration.

Authors:  Mohammad Harun-Or-Rashid; Nate Pappenhagen; Peter G Palmer; Matthew A Smith; Victoria Gevorgyan; Gina N Wilson; Samuel D Crish; Denise M Inman
Journal:  J Neurosci       Date:  2018-05-14       Impact factor: 6.167

8.  Early astrocyte redistribution in the optic nerve precedes axonopathy in the DBA/2J mouse model of glaucoma.

Authors:  Melissa L Cooper; Samuel D Crish; Denise M Inman; Philip J Horner; David J Calkins
Journal:  Exp Eye Res       Date:  2015-12-02       Impact factor: 3.467

9.  Restoration of Opa1-long isoform inhibits retinal injury-induced neurodegeneration.

Authors:  Yue Sun; Weili Xue; Zhiyin Song; Kun Huang; Ling Zheng
Journal:  J Mol Med (Berl)       Date:  2015-11-04       Impact factor: 4.599

10.  Proteomics Analysis of Molecular Risk Factors in the Ocular Hypertensive Human Retina.

Authors:  Xiangjun Yang; Gözde Hondur; Ming Li; Jian Cai; Jon B Klein; Markus H Kuehn; Gülgün Tezel
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.